US OptionsDetailed Quotes

SAVA241004C36500

Watchlist

0.07
0.000.00%

15min DelayClose Oct 2 16:00 ET

0.07High0.07Low

Cassava Sciences Stock Discussion

joe black8

14 hours ago

To zero

$Cassava Sciences (SAVA.US)$ garbage

JAYYFLASH

18 hours ago

$Cassava Sciences (SAVA.US)$Since SEC keeps ignoring and not taking action on stock manipulation but yet accepted $40M as settlement and still does nothing on stock manipulation. Here’s other ways to file complaints with evidence and times hit pieces :
File a Complaint with Another Agency: You can report the issue to other regulatory bodies, such as the Financial Industry Regulatory Authority (FINRA) or the Commodity Futures Trading Commission (CFTC), depending on the nature of the manipulation....

frogoracletrading

Sep 30 23:15

$SAVA Support / Resistance Levels

Here are the levels on this push up.
Larger Image: tradingview.com...
$Cassava Sciences (SAVA.US)$

Stevo1972

Sep 30 21:44

something I like to do everyday

I like to look at the biggest losers
first is it green in the 60 day and YTD columns and what's it's volume (higher volume the better)
If yes then i check out the companies profile (what do they do, what's there competition in that sector like).
After that check out the news, company announcements, ratings, I do all this on moomoo
Then i get on to Google, YouTube, etc, and look for anything that involves the company (there's often articles and videos from other sou...

JAYYFLASH

Sep 30 21:02

$Cassava Sciences (SAVA.US)$ Spoke with a Lawyer/ former executive yesterday who has brought many drugs to market specifically with brain functions. He stated that the number one thing that FDA and regulators look for in any drug is safety, does it cause any adverse effect when the patient started taking the drug and made things worse. As We have seen with all the other current drugs for Alzheimer's, they all cause brain bleeding, swelling and death , hence scrutinized and not recommended. SAVA h...

Night Pig

Sep 29 07:55

Interesting article on "Filamin A" and how it could potentially help with autism!

$Cassava Sciences (SAVA.US)$
https://pubmed.ncbi.nlm.nih.gov/39164108/

JAYYFLASH

Sep 29 00:33

$Cassava Sciences (SAVA.US)$ Here is the Breakdown: SAVA settled with SEC because they know that 40M is nothing compared to what they are going to make when Simufilam becomes Available. FDA still granted them 2 SPA's , agreed for them to continue with OLE Extension as many trial sites and patients requested it and has been deemed safe with several reviews. Did everyone forget about Biogen 2 years ago that Paid $900M to settle false claims but Biogen is still thriving as a company even though the...

Kevin Travers

Sep 28 04:03

Columns Wall Street Today | Slow Friday Market Sees Pull Back

The market climbed Friday after the Fed's favorite way to measure inflation came in at the lowest year-over-year increase since 2021: 2.2%. That strength was felt in the Russell 2000 and Dow Jones Industrial Average, but as tech fell and Chinese stocks pulled back their run the rest of the market felt soft.
Tech and material stocks pulled down the Nasdaq and S&P 500, even after the S&P 500 hit a trading and closing high Thursday.
Just past 4...

Luzi Ann Santos

Sep 28 02:45

Columns Cassava Sciences Stock Sinks 14% After $40 Million Settlement With SEC

$Cassava Sciences (SAVA.US)$ tumbled by about 14% after the company said it agreed to pay a $40 million in monetary penalty as part of a settlement of allegations by the Securities and Exchange Commission that its reports on a clinical trial "negligently contained materially misleading statements and omissions."
The SEC investigation included the company's regulatory disclosures regarding its phase 2b clinical trial of simufila...

JAYYFLASH

Sep 27 23:24

$Cassava Sciences (SAVA.US)$ We need to Question The SEC and DOJ and make sure they file the same charges to Eli Lilly's Donanemab. Why are they not investigated by SEC & DOJ ? Since they charged SAVA 40Million, they need hold accountable all the other ones that actually kill patients, exaggerated their data and paid 8 FDA reviewers to approve their drug that no doctor would recommend. Look at this New Article : "Investigation Discloses Safety, Efficacy Concerns About Eli Lilly's Donanemab"

No comment yet